Description

Etopozid (Etoposide) Concentrate for Infusions 20 mg/ml. 2.5 ml. (50 mg.) Vial №1

Ingredients:

Etoposide is the active ingredient in Etopozid concentrate for infusions. Other ingredients may include solvents and stabilizers necessary for the formulation.

Dosage:

The recommended dosage of Etopozid concentrate for infusions is determined by the patient’s body surface area, health condition, and the type of cancer being treated. It is administered intravenously by a healthcare professional.

Indications:

Etopozid concentrate for infusions is indicated for the treatment of various types of cancers, including lung cancer, testicular cancer, and certain types of leukemia. It works by interfering with the growth and spread of cancer cells in the body.

Contraindications:

Do not use Etopozid concentrate for infusions if you are allergic to etoposide or any of the other ingredients in the product. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking.

Directions:

Follow the instructions provided by your healthcare provider for the proper administration of Etopozid concentrate for infusions. It is essential to receive this medication in a clinical setting under the supervision of a qualified healthcare professional.

Scientific Evidence:

Etoposide, the active ingredient in Etopozid concentrate for infusions, has been extensively studied for its efficacy in treating various types of cancers. Research studies have demonstrated its ability to inhibit topoisomerase II enzyme, leading to DNA damage in cancer cells and ultimately causing cell death.

Additional Information:

Etopozid concentrate for infusions has shown promising results in clinical trials for its effectiveness in the treatment of solid tumors and hematological malignancies. It is often used in combination with other chemotherapy agents to improve treatment outcomes and patient survival rates.

Pharmacologically, Etopozid works by disrupting the DNA replication process in rapidly dividing cancer cells, thereby preventing tumor growth and metastasis. This mechanism of action makes it a valuable component in the treatment of various cancers.

Comparative studies have shown that Etopozid concentrate for infusions exhibits comparable effectiveness to other topoisomerase inhibitors while offering a favorable safety profile. Its use in different cancer types and in combination therapies highlights its versatility and importance in modern oncology.